Simone Chevalier
Affiliations: | Université de Montréal, Montréal, Canada |
Area:
BiochemistryWebsite:
https://www.certara.com/staffmember/martine-allard/Google:
"Simone Chevalier"Bio:
DOI: 10.1016/0014-2964(75)90101-2
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Walter G. Verly | grad student | 1973 | Université de Montréal | |
| (À la recherche de la chalone endométriale) | ||||
Children
Sign in to add trainee| Pierre Allard | grad student | 2000 | Université de Montréal |
| Isabelle Defoy | grad student | 2002 | Université de Montréal |
| Lucie Hamel | grad student | 2004 | Université de Montréal |
| Amina Zoubeidi | grad student | 2004 | Université de Montréal |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Derderian S, Benidir T, Scarlata E, et al. (2023) Cell-by-cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression. The Journal of Pathology. Clinical Research |
| Ebrahimizadeh W, Guérard KP, Rouzbeh S, et al. (2023) A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients. British Journal of Cancer |
| Dahmani C, Caron P, Simonyan D, et al. (2022) Preoperative Circulating 11-Oxygenated Androgens Are Associated With Metastasis-free Survival in Localized Prostate Cancer. The Journal of Urology. 101097JU000000000000 |
| Rouleau M, Nguyen Van Long F, Turcotte V, et al. (2022) Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer. British Journal of Cancer |
| Lacombe L, Hovington H, Brisson H, et al. (2022) UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways. Cancer Letters. 215994 |
| Derderian S, Vesval Q, Wissing MD, et al. (2022) Liquid biopsy-based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer. Clinical and Translational Science |
| Bramhecha YM, Guérard KP, Audet-Walsh É, et al. (2022) Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients. Oncogene |
| Emond JP, Lacombe L, Caron P, et al. (2021) Urinary oestrogen steroidome as an indicator of the risk of localised prostate cancer progression. British Journal of Cancer |
| Ebrahimizadeh W, Guérard KP, Rouzbeh S, et al. (2020) Design and development of a fully synthetic MLPA-based probe mix for detection of copy number alterations in prostate cancer formalin-fixed, paraffin-embedded tissue samples. The Journal of Molecular Diagnostics : Jmd |
| Patel PG, Wessel T, Kawashima A, et al. (2019) A three-gene DNA methylation biomarker accurately classifies early stage prostate cancer. The Prostate |